1. Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period

Nadezhda V. Maksimova , Anna V. Michenko, Olga A. Krasilnikova , Ilya D. Klabukov* , Igor Yu. Gadaev , Michael E. Krasheninnikov , Pavel A. Belkov, Aleksey V. Lyundup

Bioimpacts. 2022;12(1): 51-55. doi: 10.34172/bi.2021.22167

PMCID: PMC8783077 PMID: 35087716 Scopus ID: 85127152579

Article

PDF

Full Text

XML

Cited By:

Three-year follow-up of patients, treated for diabetic foot ulcers with mesenchymal stromal cells that revealed absence of ulcer recurrence, neoplasms, and scar contracture. Collagen ultrasound density decreased by 57% and the epidermal thickness increased by 72% in the area of healed ulcers.

Original Article

2. Preparation and evaluation of a polycaprolactone/chitosan/propolis fibrous nanocomposite scaffold as a tissue engineering skin substitute

Seyedeh-Sara Hashemi , Ali Akbar Mohammadi , Seyedeh-Somayeh Rajabi, Parisa Sanati , Alireza Rafati , Mehdi Kian* , Zahra Zarei*

Bioimpacts. 2023;13(4): 275-287. doi: 10.34172/bi.2023.26317

PMCID: PMC10460768 PMID: 37645024 Scopus ID: 85168111465

Article

PDF

Full Text

XML

Cited By:

An overview of the fabrication process of the polycaprolactone/chitosan/propolis scaffold followed by the characterization of physical, chemical, and biological properties as a proper candidate for dressing skinwounds.

Original Article

3. A human acellular dermal matrix coated with zinc oxide nanoparticles accelerates tendon repair in patients with hand flexor tendon injuries in zone 5 of the hand

Seyedeh-Sara Hashemi* , Mohsen Pirmoradi, Alireza Rafati, Mehdi Kian, Ali Akbar Mohammadi* , Mohamad Ali Hoghoughi*

Bioimpacts. 2024;14(5): 27748. doi: 10.34172/bi.2024.27748

PMCID: PMC11406428 PMID: 39296797

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons